Category: Chronic obstructive pulmonary disease

As of February 2022, the FDA approved a generic version of the brand-name drug Daliresp. This makes it possible for patients to obtain a more affordable option for their severe Chronic Obstructive Pulmonary Disease (COPD) treatment, which can help lower the risk of exacerbations.

Chronic Obstructive Pulmonary Disease (COPD) affects millions of adults worldwide, and for many, long-term management is crucial for maintaining quality of life. Brimica is a prescribed combination dry powder inhaler designed for this purpose, featuring two active ingredients that work together to open the airways and relieve symptoms.

According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), systemic steroids are standard for treating acute exacerbations. But at what stage of COPD do you take steroids, and are they suitable for long-term use?

Chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death by disease in the United States, and effective treatment is crucial for managing symptoms and improving quality of life. Deciding what is the best inhaler for COPD is not a one-size-fits-all answer, as the most effective option depends on the individual's symptoms, disease severity, and personal needs.

In 2024 and 2025, two significant new medications were approved by the FDA for chronic obstructive pulmonary disease (COPD), representing the first novel treatments in over a decade. However, to answer the question, "What is the new pill for COPD?", it's important to clarify that these major advances are actually an injectable biologic and a nebulized therapy, rather than traditional oral pills.